Neumora Therapeutics IncNASDAQ:NMRA
- LAST PRICE9.6700
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots9.2500/ 1
- Ask / Lots9.6700/ 1
- Open / Previous Close--- / 9.6700
- Day Range---
- 52 Week Range
- Volume1,054
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | NMRA |
|---|---|---|
| 09:32 ET | 11079 | 9.95 |
| 09:33 ET | 26705 | 9.79 |
| 09:35 ET | 2310 | 9.8 |
| 09:37 ET | 200 | 9.775 |
| 09:39 ET | 28134 | 9.675 |
| 09:42 ET | 2880 | 9.71 |
| 09:44 ET | 400 | 9.75 |
| 09:46 ET | 999 | 9.645 |
| 09:48 ET | 903 | 9.67 |
| 09:50 ET | 500 | 9.67 |
| 09:51 ET | 1000 | 9.67 |
| 09:53 ET | 1550 | 9.66 |
| 09:55 ET | 15719 | 9.7099 |
| 09:57 ET | 1200 | 9.635 |
| 10:00 ET | 800 | 9.66 |
| 10:02 ET | 650 | 9.645 |
| 10:04 ET | 835 | 9.63 |
| 10:06 ET | 1936 | 9.63 |
| 10:08 ET | 926 | 9.65 |
| 10:09 ET | 1304 | 9.725 |
| 10:11 ET | 648 | 9.71 |
| 10:13 ET | 8378 | 9.6753 |
| 10:15 ET | 1200 | 9.695 |
| 10:18 ET | 5710 | 9.7312 |
| 10:20 ET | 1011 | 9.75 |
| 10:22 ET | 2025 | 9.75 |
| 10:24 ET | 1250 | 9.76 |
| 10:26 ET | 3655 | 9.78 |
| 10:27 ET | 800 | 9.8 |
| 10:29 ET | 2005 | 9.78 |
| 10:31 ET | 10616 | 9.75 |
| 10:33 ET | 655 | 9.77 |
| 10:36 ET | 1400 | 9.75 |
| 10:38 ET | 504 | 9.78 |
| 10:40 ET | 687 | 9.77 |
| 10:42 ET | 200 | 9.79 |
| 10:44 ET | 100 | 9.77 |
| 10:45 ET | 300 | 9.79 |
| 10:47 ET | 500 | 9.76 |
| 10:49 ET | 500 | 9.79 |
| 10:51 ET | 404 | 9.78 |
| 10:56 ET | 100 | 9.795 |
| 10:58 ET | 4625 | 9.78 |
| 11:00 ET | 400 | 9.785 |
| 11:02 ET | 100 | 9.785 |
| 11:03 ET | 200 | 9.77 |
| 11:05 ET | 5242 | 9.8 |
| 11:07 ET | 600 | 9.77 |
| 11:09 ET | 1043 | 9.78 |
| 11:12 ET | 100 | 9.8 |
| 11:14 ET | 3108 | 9.805 |
| 11:16 ET | 1572 | 9.77 |
| 11:18 ET | 400 | 9.79 |
| 11:20 ET | 100 | 9.775 |
| 11:21 ET | 902 | 9.77 |
| 11:23 ET | 2300 | 9.79 |
| 11:25 ET | 569 | 9.8049 |
| 11:27 ET | 200 | 9.805 |
| 11:30 ET | 100 | 9.795 |
| 11:32 ET | 2687 | 9.77 |
| 11:34 ET | 964 | 9.81 |
| 11:36 ET | 1514 | 9.765 |
| 11:38 ET | 1418 | 9.75 |
| 11:39 ET | 200 | 9.75 |
| 11:41 ET | 200 | 9.75 |
| 11:43 ET | 103 | 9.7335 |
| 11:45 ET | 2500 | 9.73 |
| 11:48 ET | 300 | 9.715 |
| 11:50 ET | 350 | 9.73 |
| 11:52 ET | 700 | 9.71 |
| 11:54 ET | 1305 | 9.74 |
| 11:56 ET | 300 | 9.745 |
| 11:57 ET | 200 | 9.78 |
| 11:59 ET | 100 | 9.78 |
| 12:01 ET | 900 | 9.75 |
| 12:03 ET | 758 | 9.7454 |
| 12:06 ET | 1801 | 9.78 |
| 12:08 ET | 1850 | 9.76 |
| 12:10 ET | 300 | 9.77 |
| 12:12 ET | 400 | 9.77 |
| 12:14 ET | 2190 | 9.735 |
| 12:15 ET | 300 | 9.71 |
| 12:17 ET | 27409 | 9.71 |
| 12:19 ET | 1060 | 9.71 |
| 12:21 ET | 2252 | 9.72 |
| 12:24 ET | 1141 | 9.72 |
| 12:26 ET | 1350 | 9.72 |
| 12:28 ET | 637 | 9.73 |
| 12:30 ET | 600 | 9.74 |
| 12:32 ET | 1800 | 9.73 |
| 12:33 ET | 200 | 9.74 |
| 12:35 ET | 600 | 9.77 |
| 12:37 ET | 200 | 9.81 |
| 12:39 ET | 20492 | 9.81 |
| 12:42 ET | 200 | 9.805 |
| 12:44 ET | 300 | 9.8 |
| 12:46 ET | 300 | 9.805 |
| 12:48 ET | 876 | 9.76 |
| 12:50 ET | 1108 | 9.8065 |
| 12:51 ET | 300 | 9.795 |
| 12:53 ET | 800 | 9.78 |
| 12:55 ET | 100 | 9.8 |
| 01:00 ET | 2710 | 9.795 |
| 01:02 ET | 1811 | 9.87 |
| 01:04 ET | 100 | 9.87 |
| 01:06 ET | 2480 | 9.95 |
| 01:08 ET | 1400 | 9.95 |
| 01:09 ET | 400 | 9.96 |
| 01:11 ET | 606 | 9.94 |
| 01:13 ET | 200 | 9.94 |
| 01:15 ET | 400 | 9.93 |
| 01:18 ET | 1250 | 9.955 |
| 01:22 ET | 311 | 9.97 |
| 01:26 ET | 1164 | 9.945 |
| 01:27 ET | 758 | 9.93 |
| 01:29 ET | 7344 | 9.86 |
| 01:33 ET | 923 | 9.89 |
| 01:36 ET | 100 | 9.92 |
| 01:38 ET | 1063 | 9.92 |
| 01:42 ET | 500 | 9.92 |
| 01:44 ET | 591 | 9.91 |
| 01:45 ET | 500 | 9.91 |
| 01:47 ET | 5132 | 9.89 |
| 01:49 ET | 551 | 9.89 |
| 01:51 ET | 100 | 9.88 |
| 01:56 ET | 300 | 9.88 |
| 02:00 ET | 802 | 9.875 |
| 02:03 ET | 1222 | 9.86 |
| 02:05 ET | 1533 | 9.88 |
| 02:07 ET | 7875 | 9.885 |
| 02:09 ET | 2050 | 9.9 |
| 02:12 ET | 950 | 9.9 |
| 02:16 ET | 3070 | 9.9 |
| 02:18 ET | 1000 | 9.87 |
| 02:20 ET | 1411 | 9.865 |
| 02:21 ET | 887 | 9.845 |
| 02:23 ET | 1684 | 9.81 |
| 02:30 ET | 100 | 9.79 |
| 02:34 ET | 1457 | 9.8 |
| 02:36 ET | 300 | 9.81 |
| 02:38 ET | 734 | 9.805 |
| 02:41 ET | 100 | 9.805 |
| 02:43 ET | 200 | 9.79 |
| 02:45 ET | 500 | 9.81 |
| 02:48 ET | 742 | 9.815 |
| 02:50 ET | 304 | 9.815 |
| 02:52 ET | 100 | 9.81 |
| 02:54 ET | 700 | 9.81 |
| 02:56 ET | 200 | 9.79 |
| 02:57 ET | 1641 | 9.77 |
| 02:59 ET | 800 | 9.77 |
| 03:01 ET | 2314 | 9.76 |
| 03:03 ET | 936 | 9.76 |
| 03:06 ET | 10842 | 9.735 |
| 03:08 ET | 3009 | 9.75 |
| 03:10 ET | 200 | 9.75 |
| 03:12 ET | 1791 | 9.78 |
| 03:14 ET | 1247 | 9.775 |
| 03:15 ET | 700 | 9.71 |
| 03:17 ET | 300 | 9.715 |
| 03:19 ET | 1434 | 9.695 |
| 03:21 ET | 4636 | 9.685 |
| 03:24 ET | 800 | 9.71 |
| 03:26 ET | 400 | 9.73 |
| 03:28 ET | 400 | 9.72 |
| 03:30 ET | 1667 | 9.69 |
| 03:32 ET | 1100 | 9.71 |
| 03:33 ET | 5986 | 9.73 |
| 03:35 ET | 500 | 9.73 |
| 03:37 ET | 1402 | 9.71 |
| 03:39 ET | 800 | 9.73 |
| 03:42 ET | 4144 | 9.74 |
| 03:44 ET | 16156 | 9.76 |
| 03:46 ET | 7238 | 9.745 |
| 03:48 ET | 13365 | 9.692 |
| 03:50 ET | 12194 | 9.675 |
| 03:51 ET | 11820 | 9.715 |
| 03:53 ET | 21245 | 9.71 |
| 03:55 ET | 16892 | 9.69 |
| 03:57 ET | 36900 | 9.675 |
| 04:00 ET | 1107045 | 9.67 |
Nov 22, 2024
DJ Neumora Therapeutics Price Target Maintained With a $29.00/Share by RBC Capital, from 12:07PM ET on Friday Nov 22, 2024 by Dow Jones
12:07PM ET on Friday Nov 22, 2024 by Dow Jones
Nov 13, 2024
DJ Neumora Therapeutics Price Target Maintained With a $30.00/Share by HC Wainwright & Co., from 11:59AM ET on Wednesday Nov 13, 2024 by Dow Jones
11:59AM ET on Wednesday Nov 13, 2024 by Dow JonesDJ Neumora Therapeutics Price Target Maintained With a $23.00/Share by Needham, from 5:20AM ET on Wednesday Nov 13, 2024 by Dow Jones
5:20AM ET on Wednesday Nov 13, 2024 by Dow Jones
Nov 12, 2024
Press Release: Neumora Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update, from 7:00AM ET on Tuesday Nov 12, 2024 by Dow Jones
7:00AM ET on Tuesday Nov 12, 2024 by Dow JonesNeumora Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update, from 7:00AM ET on Tuesday Nov 12, 2024 by Dow Jones
7:00AM ET on Tuesday Nov 12, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Neumora Therapeutics Inc | 1.6B | -5.5x | --- |
Viridian Therapeutics Inc | 1.6B | -4.9x | --- |
Spyre Therapeutics Inc | 1.6B | -3.7x | --- |
Day One Biopharmaceuticals Inc | 1.4B | -13.1x | --- |
Praxis Precision Medicines Inc | 1.4B | -7.3x | --- |
Syndax Pharmaceuticals Inc | 1.4B | -4.6x | --- |
Company Information
Neumora Therapeutics Inc. is a clinical-stage biopharmaceutical company. The Company’s therapeutic pipeline consists of seven clinical and preclinical neuroscience programs that target novel mechanisms of action for a broad range of underserved neuropsychiatric disorders and neurodegenerative diseases. Its advanced product candidate, navacaprant (NMRA-140), is a novel once-daily oral kappa opioid receptor (KOR) antagonist that is being developed for the treatment of depressive disorder (MDD). Its other candidates include NMRA-266, NMRA-511, and NMRA-NMDA. NMRA-266 is a positive allosteric modulator program of the M4 muscarinic receptor (M4R) for the treatment of schizophrenia. NMRA-266 is designed to be selective for the M4 receptor subtype of the muscarinic receptor family. NMRA-511 is an investigational antagonist of the vasopressin 1a receptor (V1aR). NMRA-NMDA is an NMDA positive allosteric modulator program that the Company is developing for the treatment of schizophrenia.
Contact Information
- Headquarters
- 490 Arsenal Way, Suite 200WATERTOWN, MA, United States 02472
- Phone
- 857-760-0900
- Fax
- 302-655-5049
Executives
- Executive Chairman of the Board, Co-Founder
- Paul Berns
- President, Chief Executive Officer, Director
- Henry Gosebruch
- Co-Founder, Chief Operating Officer
- Carol Suh
- Chief Financial Officer
- Joshua Pinto
- Chief Strategy Officer
- Daljit Aurora
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $1.6B |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 161.6M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-1.77 |
Book Value | $2.95 |
P/E Ratio | -5.5x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
